|
LXRX Lexicon Pharmaceuticals Inc 1062822 |
| Balance Sheet |
|
Current Assets
|
268,606,000 |
|
Assets
|
321,123,000 |
|
Current Liabilities
|
36,046,000 |
|
Liabilities
|
142,611,000 |
|
Equity
|
178,512,000 |
|
Shares Out
|
361,492,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-157,289,000 |
|
Investing Cash Flow
|
-69,078,000 |
| Market Analysis |
Market Cap
|
582,002,447 |
|
Price
|
0.69 |
|
BVPS
|
0.49 |
|
PB
|
1.42 |
|
EPS
|
-0.78 |
|
PS
|
83.57 |
|
FCF
|
-226,367,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LXRX documents filed with the SEC.
LXRX Filings
Clear
